<DOC>
	<DOCNO>NCT02894541</DOCNO>
	<brief_summary>The purpose study investigate effect food pharmacokinetics/pharmacodynamics CKD-519 .</brief_summary>
	<brief_title>Study Investigate Effects Food Pharmacokinetics/Pharmacodynamics CKD-519</brief_title>
	<detailed_description>A randomized , open-label , single dose , 1-sequence , 3-treatment , 3-period crossover study investigate effect food pharmacokinetics/pharmacodynamics CKD-519 healthy male subject .</detailed_description>
	<criteria>Between 20 age 45 age healthy adult male Body weight 50 , Body Mass Index 18 29kg/mÂ² Necessarily agree use double contraception sperm donation two month clinical trial final dosage investigational product Those fully understand clinical trial enough hearing , decide join clinical trial comply precaution write consent Clinically significant disease cardiovascular , respiratory , hepatobiliary , nephrological , hematological , gastrointestinal , endocrine , immune , integumentary , neurologic , psychiatric system Have acute disease within 28 day begin study treatment Have disease history effect drug absorption , distribution , metabolism , excretion Have clinically significant chronic disease Systolic blood pressure &lt; 100mmHg &gt; 140mmHg , diastolic blood pressure &lt; 60mmHg &gt; 90mmHg Defined follow 12lead ECG , QTc &gt; 450msec Positive serology test ( HBsAg , antiHCV Ab , antiHIV Ab , VDRL ( Venereal Disease Research Laboratories ) ) Subject treat ethical drug within 14 day begin study treatment Subject treat overthecounter herbal medicine within 7 day begin study treatment Have clinically significant allergic disease ( except mild allergic rhinitis , allergic dermatitis drug ) Can take standard Meal Whole blood donation within 60 day prior first dose component blood donation within 20 day prior first dose Blood transfusion within 30 day Taking drug receive investigational drug within 90 day prior first dose Subject treat metabolize enzyme inducer inhibitor include barbiturate within 30 day Continuously take caffeine ( caffeine &gt; 5 cups/day ) , drink alcohol ( alcohol &gt; 210g/week ) , smoke excessive cigarette ( cigarette &gt; 10cigarettes/day ) Impossible participant clinical trial investigator 's decision include laboratory test result another reason ( example , noncompliance , disoblige manner )</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Dyslipidemia</keyword>
	<keyword>CKD-519</keyword>
	<keyword>CETP inhibitor</keyword>
	<keyword>Food Drug Interaction</keyword>
</DOC>